The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study-Reference-Cited by-同舟云学术

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study

Published:2019-08-02 Issue:10 Volume:3 Page:e10211
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Geusens Piet¹^ORCID,Oates Mary²,Miyauchi Akimitsu³,Adachi Jonathan D⁴,Lazaretti-Castro Marise⁵,Ebeling Peter R⁶^ORCID,Perez Niño Carlos Augusto⁷,Milmont Cassandra E⁸,Grauer Andreas⁸,Libanati Cesar⁹^ORCID

Affiliation:

1. Department of Internal Medicine, Rheumatology, Maastricht UMC, Maastricht, The Netherlands, and University Hasselt and ReumaClinic; Genk Belgium

2. Pacific Central Coast Health Center; Santa Maria CA USA

3. Miyauchi Medical Center; Osaka Japan

4. Department of Medicine, McMaster University; Hamilton ON Canada

5. Division of Endocrinology, Escola Paulista de Medicina, Universidade Federal de São Paulo; São Paulo Brazil

6. Department of Medicine; School of Clinical Sciences, Monash University; Clayton Australia

7. UNIENDO; Bogota Colombia

8. Amgen; Thousand Oaks CA USA

9. UCB Pharma; Brussels Belgium

Funder

Amgen and UCB Pharma

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbm4.10211/fullpdf

Reference21 articles.

1. Vertebral fractures: clinical importance and management;Kendler;Am J Med,2016

2. Underdiagnosis of osteoporotic vertebral fractures in patients with fragility fractures: retrospective analysis of over 300 patients;Bottai;Clin Cases Miner Bone Metab,2016

3. Epidemiology of vertebral fractures;Schousboe;J Clin Densitom,2016

4. Vertebral fractures and mortality in older women: a prospective study;Kado;Study of osteoporotic fractures research group. Arch Intern Med,1999

5. Risk of mortality following clinical fractures;Cauley;Osteoporosis Int,2000

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erratum: Aktuelle und zukünftige pharmakologische Therapieoptionen zur Behandlung der Osteoporose und deren Wirkmechanismen – ein Überblick;Osteologie;2024-07-26

2. Monthly treatment with romosozumab for 1 year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury;JBMR Plus;2024-05-31

3. A practical approach for anabolic treatment of bone fragility with romosozumab;Journal of Endocrinological Investigation;2024-05-24

4. Secondary osteoporosis prevention: three-year outcomes from a Fracture Liaison Service in elderly hip fracture patients;Aging Clinical and Experimental Research;2024-05-05

5. Aktuelle und zukünftige pharmakologische Therapieoptionen zur Behandlung der Osteoporose und deren Wirkmechanismen – ein Überblick;Osteologie;2024-05